Amgen's would like to make it easier for drug companies to reward doctors with cash or credit for using their drugs. And taxpayer-funded healthcare programs would have to reimburse the companies unless they could prove the rewards were kickbacks. But Medicare and Medicaid could discern that 23 drug companies had billed them for vitamins by faking approval codes as if they were prescription drugs. If the Supremes agree with Amgen, it will gut the Anti-Kickback Statute. Amgen argues that just because doctors received kickbacks doesn't mean they shouldn't get paid. They did, after all, actually treat patients. More here...
advertisement
advertisement